Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Current Assets (2021 - 2026)

Tevogen's (TVGN) quarterly Current Assets came in at $2.1 million in Q1 2026, down 30.44% on a YoY basis from $3.1 million in Q1 2025, and up 39.05% quarter-over-quarter from $1.5 million in Q4 2025.

Analysis

Tevogen (TVGN) Current Assets (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Current Assets for 6 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets fell 30.44% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 30.44% YoY), and the FY2025 full-year result was $1.5 million, down 34.78% from the prior year.
  • Current Assets advanced to $2.1 million in Q1 2026 per TVGN's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $3.5 million in Q3 2024 and bottomed at $97064.0 in Q1 2023.
  • Historically, Current Assets has averaged $1.6 million across 5 years, with a median of $1.7 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Current Assets tumbled 86.78% in 2023, then jumped 2372.51% in 2024.
  • Over 5 years, Current Assets stood at $274356.0 in 2022, then surged by 528.01% to $1.7 million in 2023, then jumped by 37.02% to $2.4 million in 2024, then plunged by 34.78% to $1.5 million in 2025, then jumped by 39.05% to $2.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $2.1 million, $1.5 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.06 Bn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 2.37 Bn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 464.26 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 1.23 Bn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 834.27 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 1.18 Bn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 134.38 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 2.22 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 264.73 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.14 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 2.12 Mn
Jun 30, 2025 2.06 Mn
Mar 31, 2025 3.08 Mn
Dec 31, 2024 2.36 Mn
Sep 30, 2024 3.53 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 2.40 Mn
Dec 31, 2023 1.72 Mn
Sep 30, 2023 399,474.00
Jun 30, 2023 699,327.00
Mar 31, 2023 97,064.00
Dec 31, 2022 274,356.00
Sep 30, 2022 418,473.00
Jun 30, 2022 594,755.00
Mar 31, 2022 734,159.00
Dec 31, 2021 791,191.00